CD40L on bone-marrow derived cells is not required for atherogenesis

被引：0
|
作者：
Bavendiek, U [1 ]
LaClair, S [1 ]
Schönbeck, U [1 ]
机构：
[1] Brigham & Womens Hosp, Boston, MA 02115 USA
来源：
CIRCULATION | 2003年 / 108卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
770
引用
收藏
页码：163 / 163
页数：1
相关论文
共 50 条
  • [1] Soluble CD40L levels in bone marrow donation
    Wenzel, F.
    Heke, M.
    Hauser, M.
    Rox, J.
    Fischer, J.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S360 - S360
  • [2] Modulation of CD40/CD40L expression by factors involved in atherogenesis
    Frediani, D
    Cobra, AL
    Passaglia, MRT
    Hermann, L
    Souza, HP
    FASEB JOURNAL, 2003, 17 (04): : A522 - A523
  • [3] Atherogenesis in mice does not require CD40 ligand from bone marrow-derived cells
    Bavendiek, U
    Zirlik, A
    LaClair, S
    MacFarlane, L
    Libby, P
    Schönbeck, U
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (06) : 1244 - 1249
  • [4] DISTRIBUTION AND FUNCTION OF CD40/CD40L IN THE BONE MARROW GRANULOCYTIC PROGENITOR AND PRECURSOR CELLS. POSSIBLE PATHOPHYSIOLOGIC SIGNIFICANCE
    Mavroudi, I.
    Papadaki, V.
    Velegraki, M.
    Eliopoulos, A.
    Papadaki, H.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 236 - 237
  • [5] Delayed addition of CD40L is required to obtain optimal maturation of dendritic cells (DC) derived from CD34+cells.
    Loudovaris, M
    Baratelli, F
    Tseng-Law, J
    Aono, F
    Bender, J
    BLOOD, 1999, 94 (10) : 38A - 38A
  • [6] PLATELET CD40L DOES NOT AFFECT ATHEROGENESIS, BUT IS A KEY PLAYER IN ATHEROTHROMBOSIS
    Lacy, M.
    Gerdes, N.
    Ahmadsei, M.
    Karshovska, E.
    Kuipers, M.
    Heemskerk, J.
    Buerger, C.
    Reim, S.
    Weber, C.
    Atzler, D.
    Lutgens, E.
    ATHEROSCLEROSIS, 2019, 287 : E48 - E48
  • [7] CD40L modulates transcriptional signatures of neutrophils in the bone marrow associated with development and trafficking
    Franca, Tabata Takahashi
    Al-Sbiei, Ashraf
    Bashir, Ghada
    Mohamed, Yassir Awad
    Salgado, Ranieri Coelho
    Barreiros, Lucila Akune
    da Silva Napoleao, Sarah Maria
    Weber, Cristina Worm
    Severo Ferreira, Janaira Fernandes
    Aranda, Carolina Sanchez
    Prando, Carolina
    de Barros Dorna, Mayra B.
    Jurisica, Igor
    Fernandez-Cabezudo, Maria J.
    Ochs, Hans D.
    Condino-Neto, Antonio
    Al-Ramadi, Basel K.
    Cabral-Marques, Otavio
    JCI INSIGHT, 2021, 6 (16)
  • [8] CD40 ligand (CD40L) is an anti-apoptotic factor for bone cells.
    Ahuja, SS
    Zhao, S
    Bellido, T
    Plotkin, LI
    Sato, N
    Bonewald, LF
    JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 : S345 - S345
  • [9] CD40L and TNF both activate the classical NF-κB pathway, which is not required for the CD40L induced alternative pathway in endothelial cells
    Seigner, J.
    Basilio, J.
    Resch, U.
    de Martin, R.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 495 (01) : 1389 - 1394
  • [10] Functional maturation of mouse bone marrow-derived dendritic cells through electroporation of mRNA encoding CD40L, CD70 and caTLR4
    Van Lint, Sandra
    Pen, Joeri
    Heirman, Carlo
    Robays, Lander
    Thielemans, Kris
    Bonehill, Aude
    HUMAN GENE THERAPY, 2008, 19 (10) : 1109 - 1110
12345